Botox Azzalure — 3 Areas

A three-area botulinum toxin treatment using Azzalure (Dysport) targeting the three most common upper-face dynamic wrinkle zones — horizontal forehead lines, vertical glabellar frown lines between the brows, and lateral crow's feet around the eyes.

The Botox Azzalure 3 Areas treatment at Spire Clinic uses Azzalure (abobotulinumtoxinA, marketed internationally as Dysport), a botulinum toxin type A product manufactured by Galderma. Azzalure works by temporarily blocking the release of acetylcholine at the neuromuscular junction, reducing the contractile force of the injected muscles and softening the dynamic wrinkles they create during facial expression. The three-area protocol addresses the upper face comprehensively. The frontalis muscle receives injections to soften horizontal forehead lines that deepen with brow elevation. The corrugator supercilii and procerus muscles between the eyebrows are treated to reduce vertical glabellar frown lines — the '11 lines' that can create an unintentionally stern or tired appearance. The orbicularis oculi muscle around the outer eyes is treated to diminish crow's feet that fan outward during smiling. Azzalure differs from Botox (onabotulinumtoxinA) in its unit potency and diffusion characteristics. Azzalure units are not interchangeable with Botox units — the dosing is product-specific. Some practitioners favour Azzalure for its slightly broader diffusion pattern, which can produce a natural-looking spread across larger muscle groups like the frontalis, though this is a matter of clinical preference and technique. Onset of effect typically begins 2-5 days after injection, with full results visible at 10-14 days. Duration averages 3-4 months, varying with individual metabolism, muscle mass, and activity level. The treatment takes approximately 30 minutes including consultation and marking, with no downtime — patients can return to normal activities immediately, avoiding only vigorous exercise, alcohol, and lying flat for 4 hours post-treatment.